Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence.
Guerrero M, Ferrín G, Rodríguez-Perálvarez M, González-Rubio S, Sánchez-Frías M, Amado V, Pozo JC, Poyato A, Ciria R, Ayllón MD, Barrera P, Montero JL, de la Mata M. Guerrero M, et al. Among authors: barrera p. Int J Mol Sci. 2019 Jan 15;20(2):336. doi: 10.3390/ijms20020336. Int J Mol Sci. 2019. PMID: 30650598 Free PMC article.
Adjuvant chemotherapy for prevention of recurrence of invasive hepatocellular carcinoma after orthotopic liver transplantation.
Bernal E, Montero JL, Delgado M, Fraga E, Costán G, Barrera P, López-Vallejos P, Solórzano G, Rufián S, Briceño J, Padillo J, López-Cillero P, Marchal T, Muntané J, de la Mata M. Bernal E, et al. Among authors: barrera p. Transplant Proc. 2006 Oct;38(8):2495-8. doi: 10.1016/j.transproceed.2006.08.053. Transplant Proc. 2006. PMID: 17097979
Everolimus is safe within the first month after liver transplantation.
Rodríguez-Perálvarez M, Pérez-Medrano I, Guerrero-Misas M, González V, Poyato A, Barrera P, Ferrín G, Pozo JC, Sánchez-Frías M, Ciria R, Briceño J, Montero JL, De la Mata M. Rodríguez-Perálvarez M, et al. Among authors: barrera p. Transpl Immunol. 2015 Oct;33(2):146-51. doi: 10.1016/j.trim.2015.09.002. Epub 2015 Sep 24. Transpl Immunol. 2015. PMID: 26392195
Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy.
Rodríguez-Perálvarez M, García-Caparrós C, Tsochatzis E, Germani G, Hogan B, Poyato-González A, O'Beirne J, Senzolo M, Guerrero-Misas M, Montero-Álvarez JL, Patch D, Barrera P, Briceño J, Dhillon AP, Burra P, Burroughs AK, De la Mata M. Rodríguez-Perálvarez M, et al. Among authors: barrera p. Transpl Int. 2015 Apr;28(4):455-64. doi: 10.1111/tri.12514. Epub 2015 Jan 16. Transpl Int. 2015. PMID: 25557691 Free article.
[Prognostic factors associated with postoperative complications in liver transplant].
Rodríguez-Ariza A, Monrobel A, Martínez-Galisteo E, Alicia Padilla C, Bárcena JA, Fraga E, Costán G, Barrera P, Poyato A, Montero JL, López-Cillero P, Muntané J, de la Mata M. Rodríguez-Ariza A, et al. Among authors: barrera p. Rev Esp Enferm Dig. 2008 Mar;100(3):129-38. doi: 10.4321/s1130-01082008000300002. Rev Esp Enferm Dig. 2008. PMID: 18416637 Free article. Spanish.
Calcium-dependent nitric oxide production is involved in the cytoprotective properties of n-acetylcysteine in glycochenodeoxycholic acid-induced cell death in hepatocytes.
González-Rubio S, Linares CI, Bello RI, González R, Ferrín G, Hidalgo AB, Muñoz-Gomariz E, Rodríguez BA, Barrera P, Ranchal I, Durán-Prado M, Aguilar-Melero P, De la Mata M, Muntané J. González-Rubio S, et al. Among authors: barrera p. Toxicol Appl Pharmacol. 2010 Jan 15;242(2):165-72. doi: 10.1016/j.taap.2009.10.003. Epub 2009 Oct 23. Toxicol Appl Pharmacol. 2010. PMID: 19837105
Mitochondrial-driven ubiquinone enhances extracellular calcium-dependent nitric oxide production and reduces glycochenodeoxycholic acid-induced cell death in hepatocytes.
González-Rubio S, Hidalgo AB, Ferrín G, Bello RI, González R, Gahete MD, Ranchal I, Rodríguez BA, Barrera P, Aguilar-Melero P, Linares CI, Castaño JP, Victor VM, De la Mata M, Muntané J. González-Rubio S, et al. Among authors: barrera p. Chem Res Toxicol. 2009 Dec;22(12):1984-91. doi: 10.1021/tx900327t. Chem Res Toxicol. 2009. PMID: 20020783
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.
Sangro B, Gomez-Martin C, de la Mata M, Iñarrairaegui M, Garralda E, Barrera P, Riezu-Boj JI, Larrea E, Alfaro C, Sarobe P, Lasarte JJ, Pérez-Gracia JL, Melero I, Prieto J. Sangro B, et al. Among authors: barrera p. J Hepatol. 2013 Jul;59(1):81-8. doi: 10.1016/j.jhep.2013.02.022. Epub 2013 Mar 4. J Hepatol. 2013. PMID: 23466307 Clinical Trial.
165 results